Skip to Content

The Medical Letter on Drugs and Therapeutics
Objective, peer-reviewed evaluations of new FDA-approved drugs, and new information on previously approved drugs.
November 24, 2014 (Issue 1456)
  • Antiviral Drugs for Influenza 2014-2015
  • Invokamet and Xigduo XR: Two New Combinations for Type 2 Diabetes
  • Pirfenidone (Esbriet) and Nintedanib (Ofev) for Idiopathic Pulmonary Fibrosis
  • Secondary Prevention of Stroke
  • Topiramate Extended-Release Capsules (Qudexy XR)
  • In Brief: Adding Ezetimibe to a Statin Improves Clinical Outcomes
Treatment Guidelines from The Medical Letter
Unbiased reviews of drug classes used to treat common disorders. Includes the doses, adverse effects and the recommendations of expert reviewers.
June 2014 (Issue 142)
  • Vaccines recommended for adults residing in the US are reviewed here. Vaccines for travel have been reviewed separately.

    Eight vaccines are currently recommended by the US Advisory Committee on Immunization Practices (ACIP) for routine use in adults at various ages... [more]